Acknowledgements The authors acknowledge Q
Alex Sinclair , a neurologist at the University of Birmingham in the U.K
Similar content being viewed by others Background Antibiotic resistance is a major concern that is becoming a global problem worldwide due to the fast evolution of genetic exchange among bacterial species, so most potent antibiotics rapidly lose their efficacy
In Poland, with limited reimbursement of new antihyperglycaemic agents, the most readily available and affordable classes of agents are sulfonylurea derivatives, PPAR- agonists, and acarbose [125, 256, 257]
Dosage forms may vary, including injections and oral tablets, depending on the specific brand and condition being treated